Global Transplant Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Transplant Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Solid Organ Transplantation
  • 1.3.3 Stem Cell Transplantation
  • 1.3.4 Soft Tissue Transplantation
  • 1.3.5 Bone Marrow Transplantation
• 1.4 Market by Application
  • 1.4.1 Global Transplant Diagnostics Market Share by Application: 2020 VS 2026
  • 1.4.2 Independent Reference Laboratories
  • 1.4.3 Hospitals & Transplant Centers
  • 1.4.4 Research Laboratories & Academic Institutes
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Transplant Diagnostics Market Perspective (2015-2026)
• 2.2 Transplant Diagnostics Growth Trends by Regions
  • 2.2.1 Transplant Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Transplant Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Transplant Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Transplant Diagnostics Industry Dynamic
  • 2.3.1 Transplant Diagnostics Market Trends
  • 2.3.2 Transplant Diagnostics Market Drivers
  • 2.3.3 Transplant Diagnostics Market Challenges
  • 2.3.4 Transplant Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Transplant Diagnostics Players by Market Size
  • 3.1.1 Global Top Transplant Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Transplant Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Transplant Diagnostics Revenue
• 3.4 Global Transplant Diagnostics Market Concentration Ratio
  • 3.4.1 Global Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Transplant Diagnostics Revenue in 2019
• 3.5 Key Players Transplant Diagnostics Area Served
• 3.6 Key Players Transplant Diagnostics Product Solution and Service
• 3.7 Date of Enter into Transplant Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Transplant Diagnostics Breakdown Data by Type

• 4.1 Global Transplant Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Transplant Diagnostics Forecasted Market Size by Type (2021-2026)

5 Transplant Diagnostics Breakdown Data by Application

• 5.1 Global Transplant Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Transplant Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Transplant Diagnostics Market Size (2015-2026)
• 6.2 North America Transplant Diagnostics Market Size by Type (2015-2020)
• 6.3 North America Transplant Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Transplant Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Transplant Diagnostics Market Size (2015-2026)
• 7.2 Europe Transplant Diagnostics Market Size by Type (2015-2020)
• 7.3 Europe Transplant Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Transplant Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Transplant Diagnostics Market Size (2015-2026)
• 8.2 Asia-Pacific Transplant Diagnostics Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Transplant Diagnostics Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Transplant Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Transplant Diagnostics Market Size (2015-2026)
• 9.2 Latin America Transplant Diagnostics Market Size by Type (2015-2020)
• 9.3 Latin America Transplant Diagnostics Market Size by Application (2015-2020)
• 9.4 Latin America Transplant Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Transplant Diagnostics Market Size (2015-2026)
• 10.2 Middle East & Africa Transplant Diagnostics Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Transplant Diagnostics Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Transplant Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 BD
  • 11.1.1 BD Company Details
  • 11.1.2 BD Business Overview
  • 11.1.3 BD Transplant Diagnostics Introduction
  • 11.1.4 BD Revenue in Transplant Diagnostics Business (2015-2020))
  • 11.1.5 BD Recent Development
• 11.2 Biofortuna
  • 11.2.1 Biofortuna Company Details
  • 11.2.2 Biofortuna Business Overview
  • 11.2.3 Biofortuna Transplant Diagnostics Introduction
  • 11.2.4 Biofortuna Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.2.5 Biofortuna Recent Development
• 11.3 Biomérieux SA
  • 11.3.1 Biomérieux SA Company Details
  • 11.3.2 Biomérieux SA Business Overview
  • 11.3.3 Biomérieux SA Transplant Diagnostics Introduction
  • 11.3.4 Biomérieux SA Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.3.5 Biomérieux SA Recent Development
• 11.4 Bio-Rad Laboratories
  • 11.4.1 Bio-Rad Laboratories Company Details
  • 11.4.2 Bio-Rad Laboratories Business Overview
  • 11.4.3 Bio-Rad Laboratories Transplant Diagnostics Introduction
  • 11.4.4 Bio-Rad Laboratories Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.4.5 Bio-Rad Laboratories Recent Development
• 11.5 Caredx
  • 11.5.1 Caredx Company Details
  • 11.5.2 Caredx Business Overview
  • 11.5.3 Caredx Transplant Diagnostics Introduction
  • 11.5.4 Caredx Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.5.5 Caredx Recent Development
• 11.6 F. Hoffman-La Roche
  • 11.6.1 F. Hoffman-La Roche Company Details
  • 11.6.2 F. Hoffman-La Roche Business Overview
  • 11.6.3 F. Hoffman-La Roche Transplant Diagnostics Introduction
  • 11.6.4 F. Hoffman-La Roche Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.6.5 F. Hoffman-La Roche Recent Development
• 11.7 Gendx
  • 11.7.1 Gendx Company Details
  • 11.7.2 Gendx Business Overview
  • 11.7.3 Gendx Transplant Diagnostics Introduction
  • 11.7.4 Gendx Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.7.5 Gendx Recent Development
• 11.8 Hologic
  • 11.8.1 Hologic Company Details
  • 11.8.2 Hologic Business Overview
  • 11.8.3 Hologic Transplant Diagnostics Introduction
  • 11.8.4 Hologic Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.8.5 Hologic Recent Development
• 11.9 Illumina
  • 11.9.1 Illumina Company Details
  • 11.9.2 Illumina Business Overview
  • 11.9.3 Illumina Transplant Diagnostics Introduction
  • 11.9.4 Illumina Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.9.5 Illumina Recent Development
• 11.10 Immucor
  • 11.10.1 Immucor Company Details
  • 11.10.2 Immucor Business Overview
  • 11.10.3 Immucor Transplant Diagnostics Introduction
  • 11.10.4 Immucor Revenue in Transplant Diagnostics Business (2015-2020)
  • 11.10.5 Immucor Recent Development
• 11.11 Luminex
  • 10.11.1 Luminex Company Details
  • 10.11.2 Luminex Business Overview
  • 10.11.3 Luminex Transplant Diagnostics Introduction
  • 10.11.4 Luminex Revenue in Transplant Diagnostics Business (2015-2020)
  • 10.11.5 Luminex Recent Development
• 11.12 Merck KGaA
  • 10.12.1 Merck KGaA Company Details
  • 10.12.2 Merck KGaA Business Overview
  • 10.12.3 Merck KGaA Transplant Diagnostics Introduction
  • 10.12.4 Merck KGaA Revenue in Transplant Diagnostics Business (2015-2020)
  • 10.12.5 Merck KGaA Recent Development
• 11.13 Omixon
  • 10.13.1 Omixon Company Details
  • 10.13.2 Omixon Business Overview
  • 10.13.3 Omixon Transplant Diagnostics Introduction
  • 10.13.4 Omixon Revenue in Transplant Diagnostics Business (2015-2020)
  • 10.13.5 Omixon Recent Development
• 11.14 Qiagen
  • 10.14.1 Qiagen Company Details
  • 10.14.2 Qiagen Business Overview
  • 10.14.3 Qiagen Transplant Diagnostics Introduction
  • 10.14.4 Qiagen Revenue in Transplant Diagnostics Business (2015-2020)
  • 10.14.5 Qiagen Recent Development
• 11.15 Thermo Fisher Scientific
  • 10.15.1 Thermo Fisher Scientific Company Details
  • 10.15.2 Thermo Fisher Scientific Business Overview
  • 10.15.3 Thermo Fisher Scientific Transplant Diagnostics Introduction
  • 10.15.4 Thermo Fisher Scientific Revenue in Transplant Diagnostics Business (2015-2020)
  • 10.15.5 Thermo Fisher Scientific Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer